Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Tresha Carroll, DO
Family Practice · LONGVIEW, WA · NPI 1932132552
Verified facts
What the public records show
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
Products named in Open Payments records
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 437 | 78 |
| Gabapentin | Gabapentin | 373 | 60 |
| Amlodipine Besylate | Amlodipine Besylate | 315 | 57 |
| Levothyroxine Sodium | Levothyroxine Sodium | 286 | 37 |
| Lisinopril | Lisinopril | 255 | 59 |
| Furosemide | Furosemide | 236 | 30 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 167 | 46 |
| Pantoprazole Sodium | Pantoprazole Sodium | 160 | 24 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 158 | 28 |
| Eliquis | Apixaban | 130 | 14 |
| Tamsulosin Hcl | Tamsulosin Hcl | 114 | 20 |
| Losartan Potassium | Losartan Potassium | 112 | 24 |
| Metoprolol Tartrate | Metoprolol Tartrate | 110 | 17 |
| Potassium Chloride | Potassium Chloride | 110 | 28 |
| Januvia | Sitagliptin Phosphate | 107 | 15 |
| Metformin Hcl | Metformin Hcl | 107 | 22 |
| Metformin Hcl Er | Metformin Hcl | 102 | 23 |
| Mirtazapine | Mirtazapine | 96 | 13 |
| Omeprazole | Omeprazole | 89 | 23 |
| Baclofen | Baclofen | 84 | suppressed |
| Metoprolol Succinate | Metoprolol Succinate | 83 | 19 |
| Duloxetine Hcl | Duloxetine Hcl | 82 | 11 |
| Escitalopram Oxalate | Escitalopram Oxalate | 80 | 13 |
| Sertraline Hcl | Sertraline Hcl | 78 | 14 |
| Trazodone Hcl | Trazodone Hcl | 75 | 15 |
| Hydrochlorothiazide | Hydrochlorothiazide | 72 | 15 |
| Lovastatin | Lovastatin | 69 | 17 |
| Citalopram Hbr | Citalopram Hydrobromide | 63 | 13 |
| Jardiance | Empagliflozin | 61 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 59 | suppressed |
| Carvedilol | Carvedilol | 55 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 52 | 11 |
| Spironolactone | Spironolactone | 51 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 50 | suppressed |
| Levetiracetam | Levetiracetam | 50 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 49 | 15 |
| Bupropion Hcl Sr | Bupropion Hcl | 48 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 46 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 43 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 43 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 43 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 42 | 11 |
| Fluoxetine Hcl | Fluoxetine Hcl | 41 | 11 |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 40 | suppressed |
| Methocarbamol | Methocarbamol | 40 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 39 | suppressed |
| Naproxen | Naproxen | 39 | suppressed |
| Olanzapine | Olanzapine | 39 | suppressed |
| Xarelto | Rivaroxaban | 39 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 38 | suppressed |
| Memantine Hcl | Memantine Hcl | 38 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 38 | suppressed |
| Valsartan | Valsartan | 38 | suppressed |
| Famotidine | Famotidine | 37 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 37 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 36 | 13 |
| Propranolol Hcl | Propranolol Hcl | 36 | suppressed |
| Risperidone | Risperidone | 35 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 35 | suppressed |
| Myrbetriq | Mirabegron | 34 | suppressed |
| Atenolol | Atenolol | 31 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 31 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 31 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 31 | 19 |
| Montelukast Sodium | Montelukast Sodium | 31 | suppressed |
| Allopurinol | Allopurinol | 30 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 30 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 30 | 19 |
| Spiriva Handihaler | Tiotropium Bromide | 29 | suppressed |
| Trulicity | Dulaglutide | 29 | suppressed |
| Cephalexin | Cephalexin | 28 | 14 |
| Levemir | Insulin Detemir | 28 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 28 | suppressed |
| Bupropion Xl | Bupropion Hcl | 27 | suppressed |
| Meloxicam | Meloxicam | 27 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 25 | suppressed |
| Fentanyl | Fentanyl | 25 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 25 | suppressed |
| Pregabalin | Pregabalin | 25 | suppressed |
| Humulin R | Insulin Regular, Human | 24 | suppressed |
| Simvastatin | Simvastatin | 24 | suppressed |
| Tradjenta | Linagliptin | 24 | suppressed |
| Bumetanide | Bumetanide | 23 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 23 | suppressed |
| Ozempic | Semaglutide | 22 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 22 | suppressed |
| Prednisone | Prednisone | 21 | 16 |
| Ibuprofen | Ibuprofen | 20 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 20 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 18 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 18 | suppressed |
| Ketoconazole | Ketoconazole | 18 | suppressed |
| Lidocaine | Lidocaine | 18 | suppressed |
| Nystatin | Nystatin | 18 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 18 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 18 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 17 | 15 |
| Easy Touch Pen Needle | Pen Needle, Diabetic | 17 | suppressed |
| Novolog Flexpen | Insulin Aspart | 17 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 17 | 14 |
| Ondansetron Odt | Ondansetron | 16 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 16 | suppressed |
| Trueplus Insulin Syringe | Syringe And Needle,insulin,1ml | 16 | suppressed |
| Anastrozole | Anastrozole | 15 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 15 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 15 | suppressed |
| Klor-Con | Potassium Chloride | 15 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 14 | suppressed |
| Alprazolam | Alprazolam | 14 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 14 | suppressed |
| Methimazole | Methimazole | 14 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 14 | suppressed |
| Gemfibrozil | Gemfibrozil | 13 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 13 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 13 | 11 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 13 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 13 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 12 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 12 | suppressed |
| Clotrimazole | Clotrimazole | 12 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 12 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 12 | suppressed |
| Latanoprost | Latanoprost | 12 | suppressed |
| Nystop | Nystatin | 12 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 12 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 12 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 12 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 12 | suppressed |
| Celecoxib | Celecoxib | 11 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 11 | suppressed |
| Lactulose | Lactulose | 11 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 11 | suppressed |
| Vascepa | Icosapent Ethyl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error